254 related articles for article (PubMed ID: 30066910)
1. A random forest classifier predicts recurrence risk in patients with ovarian cancer.
Cheng L; Li L; Wang L; Li X; Xing H; Zhou J
Mol Med Rep; 2018 Sep; 18(3):3289-3297. PubMed ID: 30066910
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a SVM classifier to predict recurrence of ovarian cancer.
Zhou J; Li L; Wang L; Li X; Xing H; Cheng L
Mol Med Rep; 2018 Oct; 18(4):3589-3598. PubMed ID: 30106117
[TBL] [Abstract][Full Text] [Related]
3. Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.
Zhang Q; Sun S; Zhu C; Zheng Y; Cai Q; Liang X; Xie H; Zhou J
Mol Med Rep; 2019 Apr; 19(4):2479-2488. PubMed ID: 30720105
[TBL] [Abstract][Full Text] [Related]
4. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
5. A 19‑miRNA Support Vector Machine classifier and a 6‑miRNA risk score system designed for ovarian cancer patients.
Dong J; Xu M
Oncol Rep; 2019 Jun; 41(6):3233-3243. PubMed ID: 31002358
[TBL] [Abstract][Full Text] [Related]
6. A six‑gene support vector machine classifier contributes to the diagnosis of pediatric septic shock.
Long G; Yang C
Mol Med Rep; 2020 Mar; 21(3):1561-1571. PubMed ID: 32016447
[TBL] [Abstract][Full Text] [Related]
7. Classifier of cross talk genes predicts the prognosis of hepatocellular carcinoma.
Zhai X; Xue Q; Liu Q; Guo Y; Chen Z
Mol Med Rep; 2017 Sep; 16(3):3253-3261. PubMed ID: 28713927
[TBL] [Abstract][Full Text] [Related]
8. Screening the molecular targets of ovarian cancer based on bioinformatics analysis.
Du L; Qian X; Dai C; Wang L; Huang D; Wang S; Shen X
Tumori; 2015; 101(4):384-9. PubMed ID: 25953442
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling of mucinous epithelial ovarian cancer by weighted gene co-expression network analysis.
Zhang GH; Chen MM; Kai JY; Ma Q; Zhong AL; Xie SH; Zheng H; Wang YC; Tong Y; Lu RQ; Guo L
Gene; 2019 Aug; 709():56-64. PubMed ID: 31108164
[TBL] [Abstract][Full Text] [Related]
10. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
11. Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.
Lei J; He ZY; Wang J; Hu M; Zhou P; Lian CL; Hua L; Wu SG; Zhou J
Cancer Med; 2021 Apr; 10(8):2924-2939. PubMed ID: 33742531
[TBL] [Abstract][Full Text] [Related]
12. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer.
Chen Y; Bi F; An Y; Yang Q
J Cell Biochem; 2019 Sep; 120(9):14444-14454. PubMed ID: 31034644
[TBL] [Abstract][Full Text] [Related]
13. Feature genes in metastatic breast cancer identified by MetaDE and SVM classifier methods.
Tuo Y; An N; Zhang M
Mol Med Rep; 2018 Mar; 17(3):4281-4290. PubMed ID: 29328377
[TBL] [Abstract][Full Text] [Related]
14. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma.
Wang J; Tian Y; Chen H; Li H; Zheng S
Mol Med Rep; 2018 Jun; 17(6):8153-8160. PubMed ID: 29658607
[TBL] [Abstract][Full Text] [Related]
15. A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer.
Jiang H; Gu J; Du J; Qi X; Qian C; Fei B
Mol Med Rep; 2020 Jan; 21(1):347-359. PubMed ID: 31939629
[TBL] [Abstract][Full Text] [Related]
16. Screening of the prognostic targets for breast cancer based co-expression modules analysis.
Liu H; Ye H
Mol Med Rep; 2017 Oct; 16(4):4038-4044. PubMed ID: 28731166
[TBL] [Abstract][Full Text] [Related]
17. Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network.
Wang X; Han L; Zhou L; Wang L; Zhang LM
Oncol Rep; 2018 Nov; 40(5):2659-2673. PubMed ID: 30226545
[TBL] [Abstract][Full Text] [Related]
18. Involvement of enhancer of zeste homolog 2 in cisplatin-resistance in ovarian cancer cells by interacting with several genes.
Wang H; Yu Y; Chen C; Wang Q; Huang T; Hong F; Zhu L
Mol Med Rep; 2015 Aug; 12(2):2503-10. PubMed ID: 25955318
[TBL] [Abstract][Full Text] [Related]
19. Construction of a 26‑feature gene support vector machine classifier for smoking and non‑smoking lung adenocarcinoma sample classification.
Yang L; Sun L; Wang W; Xu H; Li Y; Zhao JY; Liu DZ; Wang F; Zhang LY
Mol Med Rep; 2018 Feb; 17(2):3005-3013. PubMed ID: 29257283
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA‑sequencing.
Liu Y; Yang Z; Du F; Yang Q; Hou J; Yan X; Geng Y; Zhao Y; Wang H
Mol Med Rep; 2017 Nov; 16(5):6674-6682. PubMed ID: 28901494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]